Literature DB >> 10030735

Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.

Y Tabuchi1, T Nakamura, T Kuniyasu, M Ohno, S Nakae.   

Abstract

The correlations of nm23-H1 expression in primary cancer lesions with the already confirmed 14 prognostic variables and survival were examined in 52 advanced colorectal cancer patients, because the clinical roles of nm23-H1 expression in the cancer lesions remain controversial. An immunohistochemical expression of nm23-H1 was found in 23 lesions (positive group) but not found in 29 lesions (negative group). No significant difference between the positive and negative groups was found according to 12 clinicopathological variables including vascular invasion, lymph node and liver metastases, and histological stage. The carcinoembryonic antigen levels (21.5+/-33.4 ng/ml) of the draining venous blood and argyrophilic nucleolar organizer regions score (3.35+/-1.36 per nucleus) of the cancer cells in the positive group were not significantly diffeent from those (34.1+/-102.9 ng/ml and 3.32+/-1.00 per nucleus, respectively) in the negative group. In addition, no significant difference was found in the survival curves or the 5-year survival rates of the positive and negative groups. From these results, it may be concluded that the nm23-H1 expression was not associated with the aforementioned prognostic variables and the prognosis of advanced colorectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030735     DOI: 10.1007/BF02482235

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Colorectal cancer patients with high risk of hematogenous metastasis: correlation with CEA levels in peripheral and draining venous blood during the period of operation.

Authors:  Y Tabuchi; H Deguchi; K Imanishi; Y Saitoh
Journal:  J Surg Oncol       Date:  1991-06       Impact factor: 3.454

2.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.

Authors:  G Bevilacqua; M E Sobel; L A Liotta; P S Steeg
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

3.  Carcinoembryonic antigen levels of peripheral and draining venous blood in patients with colorectal cancer. Correlation with survival.

Authors:  Y Tabuchi; H Deguchi; K Imanishi; Y Saitoh
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

4.  Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.

Authors:  R Barnes; S Masood; E Barker; A M Rosengard; D L Coggin; T Crowell; C R King; K Porter-Jordan; E S Wargotz; L A Liotta
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

5.  nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.

Authors:  R L Russell; K R Geisinger; R R Mehta; W L White; B Shelton; T E Kute
Journal:  Cancer       Date:  1997-03-15       Impact factor: 6.860

6.  Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

Authors:  V A Flørenes; S Aamdal; O Myklebost; G M Maelandsmo; O S Bruland; O Fodstad
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

7.  Identification of a second human nm23 gene, nm23-H2.

Authors:  J A Stahl; A Leone; A M Rosengard; L Porter; C R King; P S Steeg
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.

Authors:  A Yamaguchi; T Urano; S Fushida; K Furukawa; G Nishimura; Y Yonemura; I Miyazaki; G Nakagawara; H Shiku
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

9.  High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.

Authors:  Z S Zeng; S Hsu; Z F Zhang; A M Cohen; W E Enker; A A Turnbull; J G Guillem
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  Reduced expression of nm23 is associated with metastasis of human gastric carcinomas.

Authors:  H Nakayama; W Yasui; H Yokozaki; E Tahara
Journal:  Jpn J Cancer Res       Date:  1993-02
View more
  6 in total

Review 1.  The role of NM23 in patients with colorectal cancer: A systematic review and meta-analysis.

Authors:  Wei Han; Jun Ma; Fang Cao; Cong Zhang; Rong Zhu; Yong-Wei Hu; Min-Bin Chen; Hou-Zhong Ding
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

2.  nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma.

Authors:  S Kapitanović; T Cacev; M Berković; M Popović-Hadzija; S Radosević; S Seiwerth; S Spaventi; K Pavelić; R Spaventi
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

Review 3.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

4.  NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Authors:  Choon-Yee Tan; Christina L Chang
Journal:  Lab Invest       Date:  2017-10-09       Impact factor: 5.662

Review 5.  Reduced NM23 Protein Level Correlates With Worse Clinicopathologic Features in Colorectal Cancers: A Meta-Analysis of Pooled Data.

Authors:  Tian Yang; Bo-Zan Chen; Dan-Feng Li; Huai-Ming Wang; Xiao-Sheng Lin; Hong-Fa Wei; Yong-Ming Zeng
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

Review 6.  Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis.

Authors:  Wei Han; Chun-Tao Shi; Fei-Yun Cao; Fang Cao; Min-Bin Chen; Rong-Zhu Lu; Hua-Bing Wang; Min Yu; Da-Wei He; Qing-Hua Wang; Jie-Feng Wang; Xuan-Xuan Xu; Hou-Zhong Ding
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.